全球 MicroRNA 市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

全球 MicroRNA 市场需求预计将从 2023 年的 24.5 亿美元增至 2032 年的近 74.9 亿美元，2024-2032 年研究期间复合CAGR为 13.24%。

MicroRNA (miRNA) 是非编码 RNA 分子，通常由约 20-22 个核苷酸组成，透过与特定信使 RNA (mRNA) 分子结合发挥作用，从而影响其稳定性和翻译成蛋白质。这些短 RNA 序列有助于基因表现的调节。

市场动态

microRNA 市场是由分子生物学研究领域不断扩大所推动的，重点在于 microRNA 在基因调控中的复杂作用。人们越来越认识到 microRNA 作为疾病（特别是癌症和心血管疾病）有价值的生物标记物，有助于将其纳入研究和诊断。定序技术的进步实现了 microRNA 表现谱的高通量分析，促进了研究和临床应用的采用。 microRNA 的诊断和治疗潜力推动了市场的发展，促进了药物开发、标靶发现和个人化医疗的探索。正在进行的癌症研究强调了 microRNA 在肿瘤学中的重要性，进一步推动了市场成长。政府资助、合作倡议和检测方法的技术创新增强了 microRNA 研究工具的能力和范围。随着慢性病发病率的上升，人们对了解 microRNA 在疾病发病机制中的作用的需求不断增加，从而推动了 microRNA 市场的扩张。随着该领域的不断发展，microRNA 研究有望推动不同医疗应用的诊断和治疗。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球微生物市场的每个细分市场进行了包容性评估。微米产业的成长和趋势为本研究提供了整体方法。

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲地区 MicroRNA 市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。 MicroRNA市场的主要参与者包括Thermo Fisher Scientific Inc.、QIAGEN、Horizo​​n Discovery Group plc、NanoString Technologies, Inc.、Merck KGaA、Takara Bio Inc.、LGC Limited、BioGenex、GeneCopoeia Inc、New England Biolabs。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：MICRORNA - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品和服务分類的市场吸引力分析
  • 市场吸引力分析：依应用分类
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球 MICRORNA 市场分析：依产品与服务分类

• 产品和服务概览
• 历史和预测数据
• 按产品和服务分析
• 服务（类型、样本）
• 产品（仪器、工作流程、消耗品、全血）

第 6 章：全球 MICRORNA 市场分析：依应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 癌症
• 传染性疾病
• 免疫失调
• 心血管疾病
• 神经系统疾病
• 其他的

第 7 章：全球 MICRORNA 市场分析：依最终用途分类

• 按最终用途分類的概述
• 历史和预测数据
• 按最终用途分析
• 生技与製药公司
• 学术和政府研究机构
• 其他的

第 8 章：全球 MICRORNA 市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：MICRORNA 公司的竞争格局

• 微米市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• Thermo Fisher Scientific Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• QIAGEN
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Horizon Discovery Group plc
• 公司简介
• 公司收入
• 产品
• 最近的发展
• NanoString Technologies Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Merck KGaA
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Takara Bio Inc
• 公司简介
• 公司收入
• 产品
• 最近的发展
• LGC Limited
• 公司简介
• 公司收入
• 产品
• 最近的发展
• BioGenex
• 公司简介
• 公司收入
• 产品
• 最近的发展
• GeneCopoeia Inc
• 公司简介
• 公司收入
• 产品
• 最近的发展
• New England Biolabs
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for MicroRNA Market is presumed to reach the market size of nearly USD 7.49 BN by 2032 from USD 2.45 BN in 2023 with a CAGR of 13.24% under the study period 2024 - 2032.

MicroRNA (miRNA) are non-coding RNA molecules typically consisting of about 20-22 nucleotides that function by binding to specific messenger RNA (mRNA) molecules, thereby influencing their stability and translation into proteins. These short RNA sequences assist in the regulation of gene expression.

MARKET DYNAMICS

The microRNA market is driven by the expanding landscape of molecular biology research, with a focus on the intricate role of microRNAs in gene regulation. Increasing awareness of microRNAs as valuable biomarkers for diseases, particularly in cancer and cardiovascular disorders, contributes to their integration into research and diagnostics. Advancements in sequencing technologies enable high-throughput analysis of microRNA expression profiles, fostering adoption in research and clinical applications. The market is propelled by the diagnostic and therapeutic potential of microRNAs, prompting exploration in drug development, target discovery, and personalized medicine. Ongoing cancer research emphasizes the significance of microRNAs in oncology, further fueling market growth. Government funding, collaborative initiatives, and technological innovations in detection methods enhance the capabilities and reach of microRNA research tools. With the rising incidence of chronic diseases, there is an increased demand for understanding the role of microRNAs in disease pathogenesis, driving the expansion of the microRNA market. As the field continues to evolve, microRNA research holds promise for advancing diagnostics and therapeutics across diverse medical applications.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of microrna. The growth and trends of microrna industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the microrna market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Products & Services

• Services (Type, Specimen)
• Products (Instruments, Workflow, Consumables, Whole Blood)

By Application

• Cancer
• Infectious Diseases
• Immunological Disorder
• Cardiovascular Disease
• Neurological Disease
• Others

By End-Use

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the MicroRNA market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the MicroRNA market include Thermo Fisher Scientific Inc., QIAGEN, Horizon Discovery Group plc, NanoString Technologies, Inc., Merck KGaA, Takara Bio Inc, LGC Limited, BioGenex, GeneCopoeia Inc, New England Biolabs. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . MICRORNA - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Products & Services
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MICRORNA MARKET ANALYSIS BY PRODUCTS & SERVICES

• 5.1 Overview by Products & Services
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Products & Services
• 5.4 Services (Type, Specimen) Historic and Forecast Sales by Regions
• 5.5 Products (Instruments, Workflow, Consumables, Whole Blood) Historic and Forecast Sales by Regions

6 . GLOBAL MICRORNA MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Cancer Historic and Forecast Sales by Regions
• 6.5 Infectious Diseases Historic and Forecast Sales by Regions
• 6.6 Immunological Disorder Historic and Forecast Sales by Regions
• 6.7 Cardiovascular Disease Historic and Forecast Sales by Regions
• 6.8 Neurological Disease Historic and Forecast Sales by Regions
• 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL MICRORNA MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-use
• 7.4 Biotechnology & Pharmaceutical Companies Historic and Forecast Sales by Regions
• 7.5 Academic & Government Research Institutes Historic and Forecast Sales by Regions
• 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL MICRORNA MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE MICRORNA COMPANIES

• 9.1. Microrna Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF MICRORNA INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Thermo Fisher Scientific Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. QIAGEN
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Horizon Discovery Group plc
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. NanoString Technologies Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Merck KGaA
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Takara Bio Inc
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. LGC Limited
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. BioGenex
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. GeneCopoeia Inc
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. New England Biolabs
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Products & Services (USD MN)
• Services (Type, Specimen) Market Sales by Geography (USD MN)
• Products (Instruments, Workflow, Consumables, Whole Blood) Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Cancer Market Sales by Geography (USD MN)
• Infectious Diseases Market Sales by Geography (USD MN)
• Immunological Disorder Market Sales by Geography (USD MN)
• Cardiovascular Disease Market Sales by Geography (USD MN)
• Neurological Disease Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Biotechnology & Pharmaceutical Companies Market Sales by Geography (USD MN)
• Academic & Government Research Institutes Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Microrna Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Microrna Report
• Market Research Process
• Market Research Methodology
• Global Microrna Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Products & Services
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Products & Services (USD MN)
• Services (Type, Specimen) Market Sales by Geography (USD MN)
• Products (Instruments, Workflow, Consumables, Whole Blood) Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Cancer Market Sales by Geography (USD MN)
• Infectious Diseases Market Sales by Geography (USD MN)
• Immunological Disorder Market Sales by Geography (USD MN)
• Cardiovascular Disease Market Sales by Geography (USD MN)
• Neurological Disease Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Biotechnology & Pharmaceutical Companies Market Sales by Geography (USD MN)
• Academic & Government Research Institutes Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.